Sign In
Buy RMD
$188.63
+2.34 (+1.26%)
At Close: Jun 18, 2026
Revisiting ResMed In 2025: Strong Q2 Financial Results And The Growing Demand For Sleep Apnea Solutions
10:38am, Monday, 10'th Feb 2025
ResMed reported $1.28 billion in revenue and $2.43 EPS, driven by strong demand for AirSense 11 and effective cost management. Rising awareness of sleep apnea, aided by wearable devices like Apple Wat
Trump Tariffs Threaten MedTech: 3 Stocks to Mitigate Risks
01:15pm, Wednesday, 05'th Feb 2025
Three companies that are better positioned to withstand Trump's tariff challenges are ResMed, Hims & Hers Health and Medtronic.
Is ResMed (RMD) a Solid Growth Stock? 3 Reasons to Think "Yes"
01:45pm, Tuesday, 04'th Feb 2025
ResMed (RMD) possesses solid growth attributes, which could help it handily outperform the market.
Stock Of The Day: Trading The Range In ResMed
12:59pm, Monday, 03'rd Feb 2025
ResMed Inc. RMD shares are consolidating on Monday. This follows Friday's decline of more than 8%.
Here's Why ResMed (RMD) is a Strong Momentum Stock
10:55am, Monday, 03'rd Feb 2025
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
ResMed Inc. (RMD) Hits Fresh High: Is There Still Room to Run?
10:16am, Friday, 31'st Jan 2025
ResMed (RMD) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues.
ResMed Inc. (RMD) Q2 2025 Earnings Call Transcript
09:10pm, Thursday, 30'th Jan 2025
ResMed Inc. (NYSE:RMD ) Q2 2025 Earnings Conference Call January 30, 2025 4:30 PM ET Company Participants Mike Ott - Senior Manager, IR Michael Farrell - Chairman and Chief Executive Officer Brett San
ResMed: Digital Health Drives Q2 Growth
07:44pm, Thursday, 30'th Jan 2025
ResMed (RMD 1.89%), a leader in sleep apnea and respiratory care solutions, reported strong fiscal 2025 second-quarter earnings on Thursday, Jan. 30. The medical device company outperformed analyst co
Compared to Estimates, ResMed (RMD) Q2 Earnings: A Look at Key Metrics
07:30pm, Thursday, 30'th Jan 2025
Although the revenue and EPS for ResMed (RMD) give a sense of how its business performed in the quarter ended December 2024, it might be worth considering how some key metrics compare with Wall Street
ResMed (RMD) Tops Q2 Earnings and Revenue Estimates
06:21pm, Thursday, 30'th Jan 2025
ResMed (RMD) came out with quarterly earnings of $2.43 per share, beating the Zacks Consensus Estimate of $2.30 per share. This compares to earnings of $1.88 per share a year ago.
ResMed beats quarterly profit estimates on demand for sleep disorder devices
05:21pm, Thursday, 30'th Jan 2025
ResMed beat Wall Street estimates for second-quarter profit on Thursday, driven by strong demand for its devices used to manage sleep apnea, a common sleep disorder.
ResMed Inc. Announces Results for the Second Quarter of Fiscal Year 2025
04:05pm, Thursday, 30'th Jan 2025
Note: A webcast of ResMed's conference call will be available at 4:30 p.m. ET today at http://investor.resmed.com
ResMed (RMD) Earnings Expected to Grow: Should You Buy?
11:06am, Thursday, 23'rd Jan 2025
ResMed (RMD) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
5 Sectors and Stocks Set to Shine This Earnings Season
12:56pm, Tuesday, 14'th Jan 2025
We have highlighted stocks from the sectors that are expected to move higher this earnings season.
Scoop Up These 4 GARP Stocks to Receive Handsome Returns
08:41am, Tuesday, 14'th Jan 2025
The GARP strategy helps investors gain exposure to stocks that have impressive prospects and are trading at a discount. OUT, COR, RJF and RMD are some stocks that hold promise.
